Legal Opinion

Lemmon Co. v. New Jersey State Board of Medical Examiners

New Jersey Superior Court Appellate Division

Decided June 26, 1980PublishedCited by 2 opinions

1Opinion of the Court

The opinion of the court was delivered by

MORGAN, J. A. D.

At issue in this appeal is the validity of a regulation adopted by the Board of Medical Examiners (hereinafter “Board”) which, in explicit terms, proscribes physician use of amphetamines or amphetamine-type drugs, classified as Schedule II controlled dangerous substances, in the treatment of exogenous obesity.

N.J.A.C. 13:35-6.16 provides:

Uses of amphetamines and sympathomimetic amine drugs(a) No physician shall prescribe, order, dispense, administer, sell or transfer any amphetamine or sympathomimetic amine drug or. compound designated…

2Cited by2 opinions

  1. Matter of Promulgation of Njac 13: 35-6.14New Jersey Superior Court Appellate Division · 1985
  2. Gate Pharmeceuticals, a Division of the Lemmon Company v. Tennessee Board of Medical ExaminersCourt of Appeals of Tennessee · 1996

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API